Srihari S. Naidu, MD, FACC, FSCAI

 

Director, Cardiac Catheterization Laboratory, Interventional Cardiology Fellowship Program & Hypertrophic Cardiomyopathy Treatment Center at Winthrop University Hospital, Mineola, NY

 

 

  • Associate Professor of Medicine (Tenure) - SUNY Stony Brook School of Medicine
  • Trustee - Society for Cardiovascular Angiography and Interventions (SCAI)
  • Trustee - Brown University, Providence, Rhode Island
  • Chair and Founder - SCAI Emerging Leader Mentorship (ELM) Program
  • President - Brown University School of Medicine Alumni Association
 

at


2010 NATIONAL LECTURES


1. Abstract Presentations, Moderator,

    CRT 2010 Conference, February 22-23,

    2010, Washington, DC

2. Hypertrophic Cardiomyopathy Update,

    Newark-Beth Israel Medical Center

    Cardiology Grand Rounds, March 4,

    2010, Newark, NJ

3. Alcohol Septal Ablation Technique,

    American College of Cardiology (ACC)

    Scientific Sessions, March 15, 2010,

    Atlanta, GA

4. Hypertrophic Cardiomyopathy Case

    Presentation, American College of

    Cardiology (ACC), March 15, 2010,

    Atlanta, GA

5. Cardiogenic Shock, Society of Cardiac

    Angiography and Intervention (SCAI)

    Scientific Sessions, May 8, 2010, San

    Diego, CA

6. Alcohol Septal Ablation: When is it the

    Right Answer? 13th Annual

    Hypertrophic Cardiomypathy

    Symposium, June 5, 2010, Hibernia, NJ

7. The Science Behind Percutaneous

    Ventricular Assist Devices, EuroPCR

    Conference, May 27, 2010, Paris, France

8. USPella Registry Update, Symposium of

    Complex Coronary and Vascular Cases,

     June 16, 2010, New York, NY

9. USPella Registry Update, C3 Complex

    Cardiovascular Catheter Conference,

     June 23, 2010, Baltimore, MD

10.PCI for STEMI, Transcatheter

    Cardiovascular Therapeutics (TCT)

    Scientific Sessions, September 21-25,

    2010, Washington, DC

11.Surviving Your First Job, Transcatheter

    Cardiovascular Therapeutics (TCT)

    Scientific Sessions, September 24, 2010,

    Washington, DC

12.Alcohol Septal Ablation Case Selection,

    Transcatheter Cardiovascular

    Therapeutics (TCT) Scientific Sessions,

    September 23, 2010, Washington, DC

13. Chair, Impella Real-World Case

    Reviews, Transcatheter Cardiovascular

    Therapeutics (TCT) Scientific Sessions,

    September 25, 2010, Washington, DC

14. Live Case Discussant - PFO Closure,

    Transcatheter Cardiovascular

    Therapeutics (TCT) Scientific Sessions,

    September 21, 2010, Washington, DC

15. Live Case Discussant - Main Arena,

    Transcatheter Cardiovascular

    Therapeutics (TCT) Scientific Sessions,

    September 25, 2010, Washington, DC

16.Complications of Percutaneous Cardiac

    Assist Devices, American Heart

    Association (AHA), November 16,

    2010, Chicago, IL

2010 PUBLICATIONS

 

1. Naidu SS, Turco M, Mauri L, et al. 

    Contemporary Incidence and Predictors

    of Major Adverse Cardiac Events

    Following Saphenous Vein Graft

    Intervention with Embolic Protection:

    An AMEthyst Trial Substudy.  Am J

    Cardiol 2010;105(8):1060-4.

2. Naidu SS.  Three Years Since the FDA

    Advisory Panel on Drug-Eluting Stents:

    What Have We Learned About Off-

    label Use and Stent Thrombosis?  J

    Invasive Cardiol 2010;22(1):21-22.

3. Khouzam R, Naidu SS, Deverapalli S. 

    Hypertrophic Cardiomyopathy:

    A Myocardial Bridge.  Online J Cardiol

    2010

4. Khouzam R, Naidu SS.  Alcohol Septal

    Ablation for Symptomatic HOCM in

    Patients with Prior Coronary Revasc-

    ularization.  J Invasive Cardiol 2010;12:

    E220-224.

5. Baldwin D, Abbott J, Trost JC, Vlachos

    HA, Selzer F, Glaser R, Wilensky RL,

    Slater JN, Doucet S, Naidu SS, Aronow

    HD, Williams DO.  A Comparison of

    Drug-eluting and Bare-metal Stents in

    Saphenous Vein Graft Lesions: A Report

    From the NHLBI Dynamic Registry.

    Am J Cardiol 2010;106(7):946-51.

6. Khouzam R, Choi D, Naidu SS.  

    Pressure Wire for Comprehensive

    Hemodynamic Assessment in Patient

    with Mechanical Aortic and Mitral

    Valves.  J Invasie Cardiol 2010;12:555-6.

7. Naidu SS.  Rethinking the Selection

    Criteria for Alcohol Septal Ablation - Is

    it Time to Push the Envelope?  J Invasive

    Cardiol 2010;12:592-3.

8. D'Elia AA, Hafiz MA, Naidu SS, Marzo

    KP.  Patient Awareness of Stent Type,

    Risk of Cardiac Events, and Symptoms

    of Myocardial Infarction Among PCI

    Pateints: A Missed Educational Oppor-

    tunity?  J Interv Cardiol 2010 (in press)

FOR A COMPLETE LIST OF PREVIOUS LECTURES AND PUBLICATIONS, PLEASE SEE FULL CURRICULUM VITAE (CV)
Document
CV

 

JOURNAL OF INVASIVE CARDIOLOGY BLOG

Dr. Naidu is one of three interventional cardiologists who write a monthly blog for the Journal of Invasive Cardiology, on a variety of topics of interest to other invasive cardiologists.  Please feel free to visit his blog page on the Journal of Invasive Cardiology website at:

 

http://www.invasivecardiology.com/blog/2831